Pro Medicus
PME.AX
#1087
Rank
S$24.18 B
Marketcap
$231.44
Share price
2.59%
Change (1 day)
193.61%
Change (1 year)

P/E ratio for Pro Medicus (PME.AX)

P/E ratio at the end of 2023: 113

According to Pro Medicus's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 450.954. At the end of 2023 the company had a P/E ratio of 113.

P/E ratio history for Pro Medicus from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202311319.24%
202294.4-44.33%
202117046.96%
2020115-9.37%
2019127123.62%
201856.915.57%
201749.3-24.9%
201665.613.96%
201557.645.17%
201439.7585.71%
20135.78-45.45%
201210.6-50.27%
201121.3130.97%
20109.23-4.23%
20099.64-2.61%
20089.90-31.32%
200714.4-22.89%
200618.76.26%
200517.623.5%
200414.2-24.72%
200318.99.15%
200217.3-22.86%
200122.5

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.